Indications for testing for proteinuria
Indications for testing for proteinuria
Dipstick urinalysis for protein is indicated
- As part of the initial assessment of patients with
- if a patient has a newly discovered GFR < 60 ml/min/1.73 m2
- if a patient has newly discovered haematuria
- newly diagnosed hypertension
- if there is unexplained oedema
- in cases of suspected heart failure
- suspected multisystem disease, e.g. SLE, systemic vasculitis
- diabetes mellitus
- As part of the annual monitoring of patients with
- biopsy-proven glomerulonephritis
- reflux nephropathy
- asymptomatic microscopic haematuria
- asymptomatic proteinuria
- Diabetes mellitus (patients with diabetes mellitus should also have annual testing for albumin:creatinine ratio if the dipstick urinalysis for protein is negative)
- Monitoring for proteinuria is also required for patients receiving treatment with gold and penicillamine
- recommendations for frequency of monitoring in the British National Formulary:
- penicillamine
- before commencing treatment and then every 1-2 weeks for the first 2 months, monthly thereafter, and in the week after any dose increase
- intramuscular gold
- before each intramuscular injection
- for oral gold, monthly
- penicillamine
- recommendations for frequency of monitoring in the British National Formulary:
Reference:
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.